The global biopharma industry is rapidly adopting the use of artificial intelligence (AI), digital transformation and innovative clinical trial designs as efficiency has become a key word in new drug development, given the massive investment and time involved.
KRSC Aims To Raise Korea’s Regulatory Science Game
Cooperation To Build Bridges And Expertise
The head of the Korea Regulatory Science Center talks exclusively to the Pink Sheet about why regulatory science is crucial, the country's efforts to improve in the area and the center's strategic bridging role.
